Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
This analysis unpacks what that data shows about optimal dosing strategy, weight-loss kinetics, and the protocol design considerations most relevant for research applications
It is not
5-Amino-1MQ is a small molecule, not a peptide, so it has no peptide bonds for digestive enzymes to cleave and can be studied orally as well as reconstituted for subcutaneous injection
consistent ~12-15% weight loss at 68 weeks Compound Tirzepatide (Zepbound) Class GIP/GLP-1 dual agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs
US$ 26.63
US$ 24.76
US$ 27.65
US$ 20.51
US$ 27.21
US$ 22.74
